There were 228 press releases posted in the last 24 hours and 437,757 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Optimi Health Submits Phase I Clinical Trial Application Combining The Use Of Proprietary Psilocybin and MDMA Drug Candidates In Healthy Therapists

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image